Pfizer's documented Antibody Dependent Enhancement (ADE) concerns
Vaccine-Associated Enhanced Disease
Antibody Dependent Enhancement (ADE) has been a major concern to anyone who has kept a close eye on the vaccine development from the beginning. Mention this to anybody as a reason not to get vaccinated and you generally get one of three reactions. Either eyes glaze over in boredom, they have no idea what you are on about or they dismiss the idea as a fringe, crack-pot conspiracy theory. Usually all three and more often than not with medical professionals.
However, it is the complete opposite of a conspiracy and is a major concern for Pfizer, the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK and the European Medicines Agency (EMA). The MHRA and the EMA both produce their reports from data supplied by Pfizer so I assume the FDA in the US and the equivalent establishments in other countries share the same concerns.
For those of you that don’t know what ADE is, it is where binding of a virus to suboptimal antibodies enhances its entry into host cells, followed by its replications. It acts like a Trojan horse to allow the virus to enter your cells and then enhance the disease that follows. This can occur after vaccination and is called Vaccine-Associated Enhanced Disease (VAED).
VAED is listed as in important potential risk in the official, confidential documents. The missing information from Pfizer is for another article but hey don’t worry about all that missing information, the vaccines are definitely safe! However, the important risk of VAED combined with that missing information means VAED is and was a very real threat. Why was Pfizer worried about VAED and with the mass vaccination rollout last winter, how can we tell if a death was caused by COVID-19 or VAED?
The rest of this article is for paid subscribers only. If you would like to learn more about VAED and why Pfizer was concerned about it, then please subscribe below. My articles take a lot of time to research and write so your support is very much appreciated and will ensure that I can continue to produce the same quality of articles going forwards.